Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2′,7′–dichlorofluorescin diacetate (DCFDA) assay by Figueroa Gonzalez, Daniela et al.
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
‘This is the peer reviewed version of the following article: 
Figueroa, D., Asaduzzaman, M., & Young, F. (2018). Real 
time monitoring and quantification of reactive oxygen 
species in breast cancer cell line MCF-7 by 2ʹ,7ʹ–
dichlorofluorescin diacetate (DCFDA) assay. Journal of 
Pharmacological and Toxicological Methods, 94, 26–33. 
https://doi.org/10.1016/j.vascn.2018.03.007 
which has been published in final form at 
https://doi.org/10.1016/j.vascn.2018.03.007
Published by Elsevier Inc. This manuscript version is made 
available under the CC-BY-NC-ND 4.0 license:
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Accepted Manuscript
Real time monitoring and quantification of reactive oxygen
species in breast cancer cell line MCF-7 by
2′,7′–dichlorofluorescin diacetate (DCFDA) assay




To appear in: Journal of Pharmacological and Toxicological Methods
Received date: 13 September 2017
Revised date: 16 March 2018
Accepted date: 27 March 2018
Please cite this article as: Daniela Figueroa, Mohammad Asaduzzaman, Fiona Young
, Real time monitoring and quantification of reactive oxygen species in breast cancer
cell line MCF-7 by 2′,7′–dichlorofluorescin diacetate (DCFDA) assay. The address for
the corresponding author was captured as affiliation for all authors. Please check if
appropriate. Jpm(2018), doi:10.1016/j.vascn.2018.03.007
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may














Real time monitoring and quantification of reactive oxygen species in breast cancer cell line 
MCF-7 by 2’,7’– dichlorofluorescin diacetate (DCFDA) assay 
Daniela Figueroa1,*, Mohammad Asaduzzaman 2, Fiona Young3 
1
Department of Medical Biotechnology, College of Medicine and Public Health, Flinders University, 
Adelaide, SA, 5052, Australia. E-mail: Daniela.Figueroa@flinders.edu.au. Ph +61 (08) 72218567 
* To whom correspondence should be addressed.  
2
Department of Medical Biotechnology, College of Medicine and Public Health, Flinders University, 
Adelaide, SA, 5052, Australia. E-mail: asad0009@flinders.edu.au 
3
Department of Medical Biotechnology, College of Medicine and Public Health, Flinders University, 
















The detection of reactive oxygen species (ROS) using 2’,7’–dichlorofluorescin diacetate (DCFDA)  
is commonly performed by a single measurement of fluorescence but this fails to capture a profile of 
ROS generation over time. This study aimed to develop a real-time monitoring method to increase the 
utility of the assay, to incorporate cytotoxicity screening and to describe the combined effects of 
DCFDA and the ROS generator, Ter-butyl hydrogen peroxide (TBHP). Breast cancer MCF-7 cells 
were loaded with DCFDA (0-50µM) for 45min, and then exposed to TBHP (0-50µM). Fluorescence 
was recorded according to three different schedules: every hour for 6h, or once after 6h or 24h. 
Viability was assessed in a crystal violet assay and cell morphology was examined by microscopy. 
TBHP caused a time and dose-dependent increase in ROS and the magnitude of the fluorescent 
signal was affected by the loading concentration of DCFDA. Reading the fluorescence every hour for 
6h did not diminish the emission signal. The most sensitive and reliable combination for this ROS 
assay was 10µM DCFDA with 25µM TBHP; since higher concentrations of DCFDA compromised cell 
viability. In conclusion we adapted a single point ROS assay to enable production of a profile of ROS 
generation over an extended 6h period, and related this to cell viability and morphology. 
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Reactive oxygen species (ROS) are highly reactive molecules with one or more 
unpaired electrons produced by the reduction of oxygen (Fan & Li, 2014; Gomes, 
Fernandes, & Lima, 2005; Valko et al., 2007). Common ROS include superoxide radical (O2
-
), hydroperoxyl radical (HO2
-), hydroxyl radical (HO-), peroxyl radical (ROO-), alkoxyl radical 
(RO-), hydrogen peroxide (H2O2), singlet oxygen (
1O2), nitric oxide (NO) and hypochlorous 
acid (HOCl) (Fink, 2002; Gomes et al., 2005; Murrant & Reid, 2001).  
Exposure to UV light, radiation, chemotherapeutics or infectious agents may induce 
the production of ROS (Cooke, Evans, Dizdaroglu, & Lunec, 2003; Halliwell, 1991) and ROS 
are also produced within the body as a by-product of respiratory metabolic processes 
facilitated by mitochondrial electron transport chains, NADPH oxidase, cytochrome P450 
reductase, xanthine oxidase and nitric oxide synthase (Dröge, 2002; Finkel, 2011; 
Gutteridge & Halliwell, 2010; Halliwell, 1991; Li & Shah, 2004; Valko et al., 2007). ROS also 
play an essential role as second messengers in different intracellular signalling processes (Li 
& Shah, 2004). ROS production and elimination is mediated by a wide range of enzymatic 
and non-enzymatic molecules with strong reductive power (Li & Shah, 2004; Verbon, Post, & 
Boonstra, 2012). The balance between these two processes (ROS generation and ROS 
scavenging) is known as cellular “redox state” (Fan & Li, 2014). When there is an alteration 
of this balance, either by overproduction of ROS or depletion of the antioxidant defence 
molecules, oxidative stress occurs, which causes the oxidation of lipids, tissue proteins, DNA 
and other biomolecules, and can lead to aberrant cell signalling, dysfunctional redox control, 
apoptosis and cell death (Gomes et al., 2005).  
Detection of ROS is commonly used to assess the mechanism of action of different 
drugs and compounds, and is also used as a marker for biological functions and cell cycle 
progression (Lautraite, Bigot-Lasserre, Bars, & Carmichael, 2003). Some reactive oxygen 
species have a very short half-life; for instance OH radicals have a T1/2 of approximately 10
-9 
seconds; therefore they exert effects close to their site of generation (Forkink, Smeitink, 
Brock, Willems, & Koopman, 2010; Valko et al., 2007). Other molecules like O2














have longer half-lives, with approximate values of 10-6 and 10-5 seconds respectively; these 
molecules have wider diffusion distances, moving within and between cells to interact with 
redox-sensitive molecules that in turn regulate cell cycle progression (Giorgio, Trinei, 
Migliaccio, & Pelicci, 2007). Although the precise mechanism of ROS signalling is poorly 
understood, it is currently thought that local ROS generation induces reversible post-
translational changes at cysteine (Miki & Funato, 2012), selenocysteine (Hawkes & Alkan, 
2010), methionine (Hoshi & Heinemann, 2001) and histidine (Lee & Helmann, 2006) protein 
residues with subsequent modifications to protein conformation, binding sites and surface 
properties (Woolley, Stanicka, & Cotter, 2013). It is also well known that ROS can modulate 
the response of many important cell-signalling molecules including mitogen-activated protein 
kinases, nuclear factor-kB, tumour suppressor protein p53, and other cell cycle check point 
proteins (Li & Shah, 2004; Menon & Goswami, 2007; Vurusaner, Poli, & Basaga, 2012). 
Intracellular changes in ROS levels can therefore influence whether cells progress through 
or withdraw from the cell cycle, or undergo apoptosis (Fan & Li, 2014). The rate at which the 
cell cycle is promoted or inhibited will ultimately depend on ROS levels, and varies according 
to the type of cell, extracellular stimuli and the duration of exposure (Fan & Li, 2014). 
Different techniques have been used to quantify ROS, including electrochemical 
quantification, electro spin resonance and fluorescent signalling (Fan & Li, 2014). The 
fluorescence methodology is based on the use of suitable probes to measure ROS 
generation. Brandt and Keston (Brandt & Keston, 1965) used 2’,7’– dichlorofluorescin 
diacetate (DCFDA) as a fluorometric probe for the detection of H2O2. It was later 
demonstrated that DCFDA is oxidized by other reactive oxygen species including peroxyl 
and hydroxyl radicals (Gomes et al., 2005). DCFDA is a non-fluorescent, lipophilic and non-
ionic compound capable of diffusing and crossing the cell membrane into the cytoplasm. 
Once inside the cells, DCFDA is deacetylated by intracellular esterases, producing 2’,7’– 
dichlorofluorescin (DCFH), a non-fluorescent and membrane-impermeable compound that 
reacts with  intracellular ROS (Brandt & Keston, 1965; Rosenkranz et al., 1992; Rota, 














DCFH might vary widely with cell type, initial incubation time, DCFDA concentration, 
esterase activity and possible subsequent leakage (Chen, Zhong, Xu, Chen, & Wang, 2010).  
Experimental conditions in the DCFDA assay often vary in different studies due to the 
requirements of the experimental design and/or the preference of individual researchers. 
The lack of uniformity of experimental conditions makes it difficult to compare results from 
different studies, as it has been shown that the slope of the ROS dose-response curves 
differ greatly depending on the DCFDA concentration in the cell culture media (Wan, Zhou, & 
Kennedy, 2003; Wan, Zhou, Ware, & Kennedy, 2005). DCFDA concentrations range from 5-
50μM (Chen et al., 2010; Valko et al., 2007) and cells can be incubated with DCFDA from 
30min to 1h (Chen et al., 2010) before or after challenging the cells with a ROS analogue or 
inducer. In the presence of ROS, DCFH is oxidised to fluorescent 2’, 7’–Dichlorofluorescin 
(DCF). The emitted fluorescence is measurable by spectrofluorometry (J. H. Kim et al., 
2005) or flow cytometry (Epling et al., 1992), with the magnitude of DCF fluorescence 
proportional to ROS activity (Halliwell & Whiteman, 2004). In most cases the emitted 
fluorescence is measured once at a single designated time-point and the result used as a 
qualitative marker of cellular oxidant stress (Chen et al., 2010). Gong et al. (Gong, Yu, Yang, 
& Zhang, 2016) examined real-time ROS  production in mouse macrophages (RAW264) by 
incubating the cells with phosphorus and nitrogen doped carbon dots (PN-CDs) for 24h at 
37°C. Real time confocal imaging was used to continuously monitor the cells for 50min after 
lipopolysaccharide (LPS) exposure to induce ROS. There was a significant fluorescence 
emission which decreased gradually after exposure to LPS. Oparka et al. (Oparka et al., 
2016) investigated ROS-dependent M-H2DCFDA (5-(and-6)-chloromethyl-2′,7′-
dichlorodihydrofluorescein diacetate) oxidation in fibroblasts by measuring fluorescence 
every 1.5 minutes for 30 minutes, but to our knowledge there are no reports of studies that  
monitor ROS generation over extended periods of time in the same cells using a microplate 
fluorescence spectrophotometer. The development of a real-time measurement method for 
the determination of intracellular ROS concentration would be valuable for the elucidation of 














microplate reader will give the advantage of in situ measurement, without the need for 
trypsinization; provide a large amount of data in a short period of time and allow parallel 
cytotoxicity screening of drugs and other compounds. 
Ter-butyl hydrogen peroxide (TBHP) is a short-chain analogue of lipid 
hydroperoxides and is widely used as pro-oxidant agent in vitro because it mimics the toxic 
effect of peroxidized fatty acids (Kučera et al., 2014; Martı́n et al., 2001).TBHP is well known 
for its damaging effects towards DNA, lipids and other macromolecules, and for causing 
oxidative stress to cells (Alia, Ramos, Mateos, Bravo, & Goya, 2005). Some studies have 
also suggested that TBHP promotes peroxidation of membrane lipids more efficiently than 
H2O2 (Guidarelli, Cattabeni, & Cantoni, 1997), which makes this hydroperoxide an excellent 
compound to use when establishing and characterising optimal conditions for an assay to 
measure ROS. TBHP diffuses through cell membrane easily and generates intracellular 
alkoxyl and peroxyl radicals, as well as H2O2, in a reaction assisted by metal ions (Alia et al., 
2005; Guidarelli et al., 1997). These RO species induce several physiological alterations 
such as lipid peroxidation, oxidative DNA damage, the depletion of intracellular glutathione, 
and cell death by apoptosis or necrosis (Guidarelli et al., 1997; J.-A. Kim, Kang, Kim, Lee, & 
Lee, 1998; Sandström, 1991).  Kweon et al., (Kweon, Jung, & Sung, 2004) studied the 
cytotoxic effect of TBHP in Bovine aortic endothelial cells (BAECs). BAECs were exposed to 
1mM TBHP for 1-24h, and then assessed for cell viability using the MTT assay, and ROS 
generation with a DCF fluorometric assay. TBHP-initiated ROS generation preceded cell 
death and the oxidative stress induced by 1mM TBHP caused significant cell death (>50%) 
6h after TBHP exposure, and >90% cell death 18h later (Kweon et al., 2004).  
For over 40 years DCFDA has been used extensively as a fluorescent probe, and it 
has been assumed that DCFDA does not affect cell metabolism or viability even though few 
studies have confirmed the absence of toxicity. Bass et al., (Bass et al., 1983) pre-incubated 
human leukocytes with 5-12.5μM DCFDA for 15min,  then examined chemotactic, 
degranulation and oxidative metabolic responses. Directional migration of leukocytes was 














et al., (Mehanna, Baudouin, & Brignole-Baudouin, 2011) found that a 20min exposure to 
20μM DCFDA did not affect the viability of HTM-3 cells.  In contrast, Andoh et al., (Andoh et 
al., 2006) found that DCFDA seemed to contribute significantly to cellular anti-toxicity 
defence. In this study, HeLa cells were incubated with 10μM sodium arsenite, 1μM cadmium 
chloride and 10μM hemin in the absence or presence of 20-40μM DCFDA for 24h. Cell 
viability was monitored by measuring the activity of lactate dehydrogenase, and in a trypan 
blue exclusion assay. DCFDA protected the cells against the cytotoxic effects of hemin, 
arsenite and cadmium (Andoh et al., 2006). 
In the crystal violet staining assay (CV), dye dissolved in methanol stains the nuclei 
of live cells and fixes cells to the culture plates (Saotome, Morita, & Umeda, 1989). After 
solubilisation with acetic acid, the optical density can be measured with a 
spectrophotometer.  The crystal violet assay is an excellent alternative to enzymatic assays 
(Bechtel & Bonavida, 2001; Reid, Lang, Froscio, Humpage, & Young, 2015; Saotome et al., 
1989; Siddiqui, Shabbir, Mikhailidis, Mumtaz, & Thompson, 2006), as it does not rely on the 
metabolic function of specific enzymes (Saotome et al., 1989). Measuring cell viability after 
ROS assay would not only give more information about the effects of DCFDA, but also 
would aid in the correlation of cell response after being challenged with a ROS inducer. 
Therefore the aim of this study is to monitor real time production of ROS in the same 
cells using a DCF assay and to assess the number of viable cells on the same microplates 
after exposure to DCFDA and/or TBHP.  
Materials and methods 
Chemicals and Reagents 
All chemicals and reagents used in this study were obtained from Sigma-Aldrich 
(Australia), unless specified otherwise. The DCFDA cellular ROS detection assay kit was 
purchased from Abcam (Melbourne, Australia).  
 














100 mL 1X DCFDA kit dilution Buffer (Abcam, Australia) was prepared by mixing 10 
mL 10X dilution buffer with 90 mL ddH2O. DCFDA was diluted in 1X kit dilution buffer to 
generate a stock solution of 50μM, which was further diluted in 1X kit dilution buffer to give 5, 
10 and 25μM on the day of use. Ter-butyl hydrogen peroxide (TBHP) dilutions were 
prepared in complete RPMI with 10% FCS without phenol red, to give final concentrations of 
12.5, 25 and 50μM. The 0.5% crystal violet stain was prepared in a 50% diluted methanol 
solution. 100% Acetic acid was diluted to 33% with demineralised water and used as a 
destain solution in the crystal violet assay. 
 
Cell culture 
The MCF-7 human epithelial breast adenocarcinoma cell line was obtained from the 
America Type Culture Collection (ATCC) and maintained in RPMI media, supplemented with 
10% FCS and 1% v/v of 10,000 units/mL penicillin + 10mg/mL streptomycin. Media were 
replaced every 2-3 days and cells were harvested with 0.1% trypsin/EDTA solution and 
subcultured twice a week. Cell culture flasks containing 80% confluent cells in exponential 
growth phase were used for all experiments. 
 
Cell-free DCFDA fluorescence 
Aliquots of 50μM DCFDA or aliquots of 100μM TBHP were added to either 1X kit 
dilution buffer or to phenol red-free RPMI with or without 10%FCS to obtain a concentration 
of 10μM DCFDA or 20μM TBHP. 100μL of each solution was added to wells in dark, clear 
bottom 96-well microplates in triplicate (Greiner CELLSTAR®, Sigma-Aldrich Australia). 
Fluorescence readings were taken using a plate spectrofluorometer (VICTOR X multilabel, 
Perkin Elmer, Australia) after 1h incubation at 37°C in a humidified 5% CO2. Fluorescence 
was measured using the following settings: excitation at 495nm, emission at 530nm; 
temperature 37°C; reading mode: bottom; number of reads: 3. Wells with only 1X buffer or 














experiment was repeated on three separate occasions (n=3). Relative fluorescence units 
(RFU) were calculated by subtracting blank readings from all measurements. Plates were 
kept at 37°C in a humidified 5% CO2 incubator in the dark between readings.   
DCFDA concentration range study 
MCF-7 cells (20,000 cells per well) were added to dark, clear bottom 96-well 
microplates according to DCFDA kit manufacturer’s instructions and incubated at 37°C in 5% 
CO2 for 24h to allow adherence. Cells were washed with 1X warm phosphate buffered saline 
(PBS) and exposed to 100μL of 0, 5, 10, 25 or 50μM DCFDA in 1X kit dilution buffer for 
45min at 37°C in a humidified 5% CO2 incubator in the dark. The DCFDA solution was 
replaced with RPMI and 10% FCS and the basal ROS production detected by recording 
fluorescence according to three different schedules: every hour for a 6h incubation period, 
only once after a single 6h continuous incubation (6h+), and after 24h continuous TBHP 
exposure (24h+).  
TBHP- stimulated ROS generation; Dose-response curve 
Additional MCF-7 cells (20,000 cells per well) were added to dark, clear bottom 96-
well microplates according to DCFDA kit manufacturer’s instructions and exposed to a range 
of concentrations of DCFDA 0-50μM (described above).  DCFDA solutions were removed, 
and cells washed with 1X PBS. MCF-7 cells were then exposed to 100μL 0, 12.5, 25 or 
50μM TBHP in complete RPMI with 10% FCS without phenol red. Fluorescence was 
detected according to the 6h, 6h+, 24h+ schedule described above.  
Controls were cells in media only (background negative control), cells loaded with 
DCFDA but not exposed to TBHP (basal ROS production), wells containing DCFDA and 
TBHP but no cells, and cells exposed to ranging concentrations of TBHP (0-50 μM) without 
DCFDA (autofluorescence control). RFU were calculated by subtracting background 
readings (cells in media only), from all measurements and determining the fold change. 
Each concentration of DCFDA and TBHP was examined in two replicate wells. Each 















Cell morphology was examined using an inverted light microscope (Olympus CKX41) 
and camera (Olympus DP22). Four digital images of each well were taken with a 20X 
(0.40php) objective using an image acquisition system (DP2- SAL, Olympus). 
Cell viability study after DCFDA- cellular reactive oxygen species detection assay: 
The crystal violet (CV) assay was performed on the same MCF-7 cells that were 
examined in the DCFDA – ROS assay (described above). Media containing TBHP were 
removed and replaced with 50μL of Crystal Violet stain (0.5%). The cells were stained and 
fixed for 10min at room temperature. Excess stain was rinsed away with demineralised 
water, and cells were left to air dry overnight. 50μL of destain solution was added for 10min. 
The optical density was read at 570nm with correction at 630nm (Reid et al., 2015). A 
separate crystal violet standard curve was produced in each replicate experiment in which 
cell densities ranged from 0 – 80,000 cells per well in replicates of 6 for each cell density. To 
generate standard curves, absorbance readings were plotted against cell densities with an 
average linear correlation of R2 = 0.99 (n=3 replicate standard curves). Numbers of viable 
cells after exposure to DCFDA and/or TBHP were determined by comparison with the CV 
standard curve generated for the same replicate experiment. 
Statistical analysis 
A mixed analysis of variance (ANOVA) was performed to test the dose-dependence 
effect of DCFDA and TBHP and pair-wise comparisons with Bonferroni post-hoc adjustment 
for multiple comparisons were used to investigate statistical significance. To examine the 
effect of the three different time schedules on ROS production, an ANOVA was conducted 
that used time, DCFDA and TBHP concentrations as independent factors. Statistical 
significance was assessed by Tukey HSD and Bonferroni post-hoc tests. A one-way ANOVA 
with Tukey HSD post-hoc was conducted to examine the fluorescence signal in MCF-7 when 
loaded with varying concentrations of DCFDA, and to examine the fluorescence signal in the 
cell-free system. These statistical analyses were performed using SPSS statistics software 














To examine the effects of the DCFDA and TBHP on MCF-7 cell viability a two-way 
ANOVA with Tukey HSD post-hoc was conducted. All experiments were performed as three 
independent replicates, and all data expressed as mean ± standard deviation. 
Results 
 In cell free controls, 1h incubation of 10μM DCFDA in 1X ROS assay kit buffer 
generated the same background fluorescence as DCFDA-free buffer (Figure 1). The same 
concentration of DCFDA in phenol-red free RPMI cell culture medium, either with or without 
10% FCS, generated significantly higher levels of fluorescence than DCFDA in buffer (Figure 
1), but the presence or absence of 10% FCS had no significant effect on fluorescence. In the 
absence of DCFDA, the ROS generator TBHP (25μM) did not cause fluorescence in cell free 
























Figure 1. Cell-free 2’,7’- dichloroflurescin diacetate (DCFDA) and TBHP fluorescence. The non-specific 
background fluorescence of 10µM DCFDA or 25µM TBHP was assessed in wells containing either 1X ROS 
assay kit buffer or Phenol red-free RPMI cell culture medium with or without 10% foetal calf serum (FCS) after 1h 
incubation at 37°C in a humidified 5% CO2. Background wells contained only 1X buffer, or RPMI with or without 
10%FCS. Means ± SD of 3 independent experiments  shown. Data analysed by One-way ANOVA with Tukey’s 
post-hoc test. *p ≤ 0.05; ** p ≤ 0.01, *** p ≤ 0.0001 compared to background control. 
MCF-7 cells generated ROS in the absence of TBHP (Figures 2, 3). Background (or 
basal) fluorescence values after 6h continuous incubation were significantly higher in cells 
loaded with 50µM DCFDA (55 ± 13.02 RFU per well) than in cells loaded with 5- 25µM 
DCFDA (Figure 3). The addition of TBHP caused a significant dose-dependent increase in 
ROS generation at each time point compared to the background values from the same time-
point (Figure 2). 
A time-dependent, significant increase in fluorescence was detected up to 3h 
compared to pre-incubation readings (0h, p<0.05, Figure 2). After 3h there was no significant 




























Figure 2. TBHP-stimulated ROS generation by MCF-7 cells loaded with 25µM 2’,7’- dichloroflurescin diacetate 
(DCFDA). DCFDA fluorescence was assessed every hour for 6h in cells exposed to  0, 12.5, 25 and 50µM TBHP. 
Cells in phenol red-free RPMI without DCFDA or TBHP were used as background negative control. Means ± SD 
of 3 independent experiments  shown. Data analysed by mixed ANOVA within factor of time with pair-wise post-
















Figure 3. ROS generation by MCF-7 cells loaded with 5-50µM 2’,7’- dichloroflurescin diacetate (DCFDA). 
Background (or basal) DCFDA fluorescence in cells that were cultured for 6h culture in phenol red-free RPMI 
without TBHP. Means ± SD of 3 independent experiments  shown. Data analysed by one-way ANOVA with Tukey 














Reading the fluorescence every hour for 6 hours did not affect the emission signal, 
because there was no significant difference between the final 6th hour OD result and those 
generated by cells that were read only once, after continuous 6h incubation (Figure 4).  
Although exposure to TBHP for 6h generated the same amount of ROS as a shorter 
3h exposure (Figure 2), an extended 24h exposure to TBHP generated significantly higher 
levels of ROS than the shorter 6h exposure (Figure 4), even after accounting for the 
increase in background ROS production. 
DCFDA was required to be able to detect TBHP generated ROS, because cells 
exposed to 0-50μM TBHP in the absence of DCFDA showed no increase in fluorescence 
after 6 or 24h (data not shown). 
 
Figure 4. Effect of continuous real time monitoring on DCFDA assay. MCF-7 cells were loaded with 25µM 2’,7’- 
dichloroflurescin diacetate (DCFDA) for 45min, then exposed to 0, 12.5, 25 or 50µM TBHP for 6 or 24h. The DCF 
fluorescence was read every hour for 6h, or after 6h+ or 24h+ uninterrupted in vitro cultures. Means ± SD of 3 
independent experiments shown. Data analysed by three-way between factors ANOVA with Pair-wise post-hoc 
test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.0001 significant difference from +6h continuous exposure at same TBHP 
concentration. 
MCF-7 Cell viability after DCFDA and TBHP exposure 
When DCFDA concentrations were 0-25µM, the addition of 0 - 25µM TBHP had no 














decrease in cell viability, compared to the medium control, when cells were loaded with 
50µM DCFDA (Figure 5). 
Exposing 20,000 MCF-7 cells to the combination of 50µM DCFDA and 50µM TBHP seemed 
to be more toxic after 24h (11,655 ± 6753 cells per well) than exposing the cells to 50µM 
TBHP alone (22,032 ± 1388 cells per well) (Figure 6); however the difference in viability was 
































Figure 5. Effect of DCFDA and TBHP on MCF-7 Cell viability. Cells were loaded with 0-50µM 2’,7’- 
dichloroflurescin diacetate (DCFDA) for 45min then washed and exposed to 0, 12.5, 25 and 50µM TBHP for 6 or 
24h. Fluorescence was read every hour for 6h or after 6h+ or 24h+ uninterrupted in vitro culture. Cell viability was 
assessed by a crystal violet assay, in which cell number was obtained by comparison with a standard curve. 
Means ± SD of 3 independent experiments shown. Data were subjected to 2-way ANOVA with Tukey post-hoc 

































Figure 6. Effect of DCFDA and TBHP on MCF-7 Cell viability. Cells were loaded with 0-50µM 2’,7’- 
dichloroflurescin diacetate (DCFDA) for 45min then washed and exposed to 0, 12.5, 25 and 50µM TBHP for 24h. 
Cell morphology was examined using an inverted microscope; digital images were taken with DP2-SAL, Olympus 
acquisition system of a) Medium only control; b) DCFDA- free cells exposed to 50 µM TBHP; and c) cells loaded 
with 50µM DCFDA and exposed to 50µM TBHP for 24h. 
Discussion: 
Reactive oxygen species are difficult to measure because they are present in low 
concentrations intracellularly, and they have short lifetimes (Gomes et al., 2005). The 
majority of published studies report measurement of the ROS detection signal at only one 
time-point (Chen et al., 2010) but this single snapshot is unlikely to capture the peak or nadir 
of ROS levels in cells, and this approach is also sensitive to assay conditions such as the 
DCFDA loading concentration (Wan et al., 2003; Wan et al., 2005). This is the first study to 
characterise ROS generation in the same cells at hourly intervals for 6h, and which 
additionally describes the effects of a range of concentrations of DCFDA on ROS detection 
and cell viability. To our knowledge, this report is the first to explore a DCFDA-based assay’s 














 Under normal physiological conditions, cancer cells generate high levels of ROS to 
activate different signaling pathways that are crucial for cell proliferation and survival 
(Benhar, Engelberg, & Levitzki, 2002; Jackson & Loeb, 2001; Storz, 2005); and also express 
high levels of antioxidant molecules to regulate ROS and prevent cell damage or death 
(Cadenas, 2004; Simon, Haj-Yehia, & Levi-Schaffer, 2000). In our study, increasing levels of 
ROS in MCF-7 cells were detected in the absence of TBHP, suggesting an imbalance of the 
intracellular Redox state that could be a consequence of insufficient antioxidant molecules in 
medium supplemented with 10% FCS or insufficient ROS scavenging inside the cells (Chen 
et al., 2010), spontaneous deacetylation of DCFDA to DCF (Royall & Ischiropoulos, 1993; 
Zhou, Diwu, Panchuk-Voloshina, & Haugland, 1997),  artefactual signal due to light-induced 
oxidation (Winterbourn, 2014) or competitive inhibition of antioxidant molecules by DCFDA 
(Wrona, Patel, & Wardman, 2005). High fluorescence levels were also detected in a cell-free 
model with RPMI with or without FCS. Brubacher and Bols (2000) observed that tyrosine 
combined with ubiquitous metal contaminants of physiological buffers can result in high 
levels of oxidation, which may be wrongly interpreted as cellular ROS (Brubacher & Bols, 
2001). RPMI and other common use media contain different amino-acids, including tyrosine, 
which could potentially influence fluorescence intensity; therefore we recommend testing the 
reaction of culture media with DCFDA, as part of ROS assay establishment. Basal ROS 
production by MCF-7 cells loaded with 5 – 50µM DCFDA (in the absence of TBHP) was 
detected after 6h culture, with the apparent ROS levels dependent on the loading 
concentration of DCFDA. DCF assay results are often expressed as the net increase of 
cellular fluorescence over that of the background control group (Wan et al., 2005), but 
subtracting the basal ROS had no effect on the DCFDA dose-dependent increase in ROS 
levels.  Adding TBHP increased ROS generation to levels that exceeded the capacity of 5µM 
DCFDA to metabolise the ROS (Bass et al., 1983; Chen et al., 2010; Royall & Ischiropoulos, 
1993; Wrona et al., 2005) and ROS detection after loading cells with 25µM DCFDA and 














DCFDA concentration was not limiting after 6h culture because ROS detection values were 
higher after the extended 24h culture period, demonstrating the capacity of 25µM DCFDA for 
detecting higher ROS levels. 
Two factors seemed to affect MCF-7 cell viability; the amount of ROS stimulated by 
TBHP and the concentration of DCFDA. 50µM DCDFA was not cytotoxic to MCF-7 cells 
grown for 24h, but the addition of 50μM TBHP caused an increase in ROS and a consequent 
decrease in cell viability. The same conditions of 24h exposure and 50µM TBHP however 
were less toxic to MCF-7 cells in the absence of DCFDA, suggesting that there was an 
interaction between DCFDA, TBHP (ROS), and the culture conditions; hence we 
recommend using the lower 25µM concentration of DCFDA in order to prevent non-specific 
ROS generation. 
Real time monitoring every hour for 6h did not significantly reduce the DCFDA 
fluorescent signal; suggesting that for MCF-7 cells, the dose-dependent increase in 
fluorescent signal was not compromised by exposing the cells every hour to the detecting 
light beam of the fluorescence plate reader; validating our proposal that the DCFDA assay 
can be used to measure ongoing ROS production in real time. This is important because 
reactive oxygen species are highly reactive and extremely short-lived molecules, which can 
be generated within seconds of stimulation. ROS have also the tendency toward chain 
reaction and generation of other RO molecules (Maneesh & Jayalekshmi, 2006), triggering 
an amplified cascade of intracellular events and activation of different pathways (Liou & 
Storz, 2010).  Therefore, it is possible that shorter incubation periods could be applicable to 
the detection of intracellular ROS, with a fluorescent signal that extends over the hours as 
more detectable ROS are generated within the cells. It’s important to highlight that because 
of the non-specific oxidation of DCFDA and the multiple pathways that can lead to DCF 
fluorescence, this assay must be utilised as a qualitative marker for total ROS production, 














ROS detection is dependent on the concentration of DCFDA that maximises assay 
sensitivity and ROS detection, whilst minimising dye-induced cytotoxicity. In this study that 
balance lay between 10- 25µM DCFDA combined with a loading exposure of 45min. Cells 
loaded with 10-25µM DCFDA and exposed to 0-50µM TBHP yielded a more precise 
estimation of ROS, with a significant and dose-dependent increase in fluorescence signal in 
all three independent experiments. We conclude that MCF-7 cells can be loaded with 10-
25µM DCFDA for 45min, and that a 6h exposure to 0-50µM TBHP is sufficient to generate a 
sensitive and reproducible standard curve. The finding that the DCF fluorescent signal can 
be measured repeatedly in the same cells could potentially increase the utility of the assay 
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